Kentaro Mizuhara

Kyoto, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Alemtuzumab-based HLA-haploidentical transplantation for relapsed/refractory aggressive NK-cell leukemia

Alemtuzumab-based HLA-haploidentical transplantation for relapsed/refractory aggressive NK-cell leukemia

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: May 13, 2026

Lead poisoning diagnosed in a patient with anemia accompanied by abdominal pain

Lead poisoning diagnosed in a patient with anemia accompanied by abdominal pain

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: November 05, 2025

Primary Cutaneous CD8-positive Aggressive Epidermotropic Cytotoxic T-cell Lymphoma Complicated by Paraneoplastic Encephalitis.

Primary Cutaneous CD8-positive Aggressive Epidermotropic Cytotoxic T-cell Lymphoma Complicated by Paraneoplastic Encephalitis.

Journal: Internal medicine (Tokyo, Japan)

Published: February 02, 2025

Robust anti-myeloma effect of TAS0612, an RSK/AKT/S6K inhibitor, with venetoclax regardless of cytogenetic abnormalities.

Robust anti-myeloma effect of TAS0612, an RSK/AKT/S6K inhibitor, with venetoclax regardless of cytogenetic abnormalities.

Journal: Leukemia

Published: August 24, 2024

Prognostic model for relapsed/refractory transplant-ineligible diffuse large B-cell lymphoma utilizing the lymphocyte-to-monocyte ratio.

Prognostic model for relapsed/refractory transplant-ineligible diffuse large B-cell lymphoma utilizing the lymphocyte-to-monocyte ratio.

Journal: International journal of hematology

Published: November 06, 2023

Skeletal muscle index impacts the treatment outcome of elderly patients with diffuse large B cell lymphoma.

Skeletal muscle index impacts the treatment outcome of elderly patients with diffuse large B cell lymphoma.

Journal: Hematological oncology

Published: October 09, 2023

Triple targeting of RSK, AKT, and S6K as pivotal downstream effectors of PDPK1 by TAS0612 in B-cell lymphomas.

Triple targeting of RSK, AKT, and S6K as pivotal downstream effectors of PDPK1 by TAS0612 in B-cell lymphomas.

Journal: Cancer science

Published: May 30, 2023

miR-17-92 cluster-BTG2 axis regulates B-cell receptor signaling in mantle cell lymphoma.

miR-17-92 cluster-BTG2 axis regulates B-cell receptor signaling in mantle cell lymphoma.

Journal: Cancer science

Published: May 30, 2023

Tumour-derived exosomes promote the induction of monocytic myeloid-derived suppressor cells from peripheral blood mononuclear cells by delivering miR-106a-5p and miR-146a-5p in multiple myeloma.

Tumour-derived exosomes promote the induction of monocytic myeloid-derived suppressor cells from peripheral blood mononuclear cells by delivering miR-106a-5p and miR-146a-5p in multiple myeloma.

Journal: British journal of haematology

Published: March 21, 2023

The Rationale for the Dual-Targeting Therapy for RSK2 and AKT in Multiple Myeloma.

The Rationale for the Dual-Targeting Therapy for RSK2 and AKT in Multiple Myeloma.

Journal: International journal of molecular sciences

Published: January 25, 2022

Watchful waiting is an acceptable treatment option for asymptomatic primary ocular adnexal mucosa-associated lymphoid tissue lymphoma: A retrospective study.

Watchful waiting is an acceptable treatment option for asymptomatic primary ocular adnexal mucosa-associated lymphoid tissue lymphoma: A retrospective study.

Journal: Cancer medicine

Published: January 18, 2022

A case of neuroleukemiosis: The usefulness of nerve ultrasound as a diagnostic tool.

A case of neuroleukemiosis: The usefulness of nerve ultrasound as a diagnostic tool.

Journal: Muscle & nerve

Published: September 15, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026